Morgan Stanley upgraded Merck (NYSE: MRK) from Equalweight to Overweight with a price target of $71.00 (from $65.00).Analyst David Risinger ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE